MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Environmental Testing
20 questions · exam conditions
0:00
Environmental TestingQuestion 1 of 20

Under USP Chapter 797, what ISO classification is required for the buffer room where Category 2 sterile compounding is performed?

ISO 9 (ambient room air).
ISO 5 (same as the PEC).
ISO 6.
ISO 7.
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Environmental Testing

Practice Environmental Testing in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Environmental Testing, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Under USP Chapter 797, what ISO classification is required for the buffer room where Category 2 sterile compounding is performed?

  1. ISO 9 (ambient room air).
  2. ISO 5 (same as the PEC).
  3. ISO 6.
  4. ISO 7. (correct answer)
Explanation: USP 797 requires the buffer room where Category 2 sterile compounding occurs to meet ISO 7 classification. The buffer room must be cleaner than the ante-area (ISO 8) and provides the controlled environment within which the ISO 5 PEC operates. D correctly identifies ISO 7 as the buffer room requirement. A is incorrect because ambient air is far too contaminated for a sterile compounding buffer room. B is incorrect because ISO 5 is required for the PEC, not the entire buffer room. C is incorrect because ISO 6 is not the standard required for the buffer room under USP 797.

Question 2

A pharmacy's laminar airflow workbench (LAFW) has been certified as meeting ISO 5 requirements. Two weeks later, during routine environmental monitoring, surface sampling reveals microbial counts exceeding action levels inside the LAFW. Which of the following best explains how this could occur despite recent certification?

  1. ISO 5 certification guarantees a permanently sterile environment and the environmental monitoring results must be incorrect.
  2. Recent certification means the LAFW was functioning correctly; the monitoring error must result from improper sampling technique.
  3. This situation cannot occur because ISO 5 engineering controls are self-decontaminating.
  4. Contamination can occur from personnel errors or improper cleaning, despite ISO 5 certification focusing on particle counts. (correct answer)
Explanation: ISO certification verifies that the engineering control meets the specified particle count and airflow standards at the time of testing. However, contamination can be introduced by personnel through poor aseptic technique, inadequate garbing, improper cleaning, or surface contact errors -- none of which are prevented by the HEPA filter or airflow system. D correctly identifies these human-factor contamination pathways that can occur even in a recently certified ISO 5 environment. A is incorrect because ISO 5 certification does not guarantee permanent sterility; it certifies engineering performance, not freedom from all contamination sources. B is incorrect because dismissing the monitoring results as sampling error is premature and potentially dangerous; the more likely explanation is personnel or cleaning practices rather than a technique error. C is incorrect because ISO 5 environments are not self-decontaminating; contamination introduced by personnel or cleaning failures persists until removed.

Question 3

After a flood in the ceiling above a sterile compounding buffer room, water damage is observed on the ceiling tiles. No active water is present and the equipment appears dry. Under USP Chapter 797, which of the following best applies?

  1. Compounding may resume after repairs, decontamination, and environmental monitoring confirm air quality standards are met. (correct answer)
  2. Compounding may resume immediately because the water has dried and visible damage is limited to ceiling tiles.
  3. Compounding may resume after a one-week waiting period to allow the area to dry thoroughly.
  4. Compounding may resume after the damaged ceiling tiles are replaced.
Explanation: Water damage to a sterile compounding area is a serious contamination event that can introduce mold, bacteria, and endotoxins. Under USP Chapter 797, compounding must not resume until the damaged areas have been fully repaired and replaced, intensive cleaning and decontamination have been completed, and follow-up environmental monitoring has confirmed that the area meets required air quality standards. A correctly identifies this comprehensive remediation requirement. B is incorrect because apparent dryness and intact equipment do not eliminate contamination risk from mold, bacterial growth, or endotoxins introduced by water damage. C is incorrect because a waiting period alone without active remediation and confirmed monitoring does not establish that the environment is safe for sterile compounding. D is incorrect because replacing ceiling tiles alone without cleaning, decontamination, and confirmed environmental monitoring results is insufficient to restore compounding readiness.

Question 4

A sterile compounding pharmacy outsources its environmental monitoring to a third-party certified environmental monitoring company. The company performs the sampling and reports results to the pharmacy. Which of the following best describes the pharmacy's compliance obligations regarding these outsourced results?

  1. Once outsourced, the pharmacy has no further compliance obligations related to environmental monitoring.
  2. The pharmacy must review results and ensure compliance with USP 797 requirements. (correct answer)
  3. The pharmacy's only obligation is to pay the invoice from the environmental monitoring company.
  4. The pharmacy may use the contractor's results only if the contractor is DEA-registered.
Explanation: Outsourcing environmental monitoring does not transfer the pharmacy's compliance obligations. The pharmacy must still review results, respond to exceedances, implement corrective actions, maintain records, and ensure the contractor's methods comply with USP 797. B correctly identifies these continuing obligations. A is incorrect because compliance responsibility remains with the pharmacy regardless of outsourcing. C is incorrect because financial obligation is not the extent of the pharmacy's responsibility. D is incorrect because DEA registration is irrelevant to environmental monitoring contractor qualification.

Question 5

A pharmacy's USP 800 wipe sampling results show hazardous drug residue above the established threshold in the ante-area outside the hazardous drug buffer room. Which of the following best describes the required response?

  1. No action is required because ante-areas are expected to have some contamination.
  2. Post a warning sign in the ante-area but continue operations.
  3. Continue operations but increase wipe sampling frequency.
  4. Investigate contamination source, decontaminate area, implement corrective measures, and confirm with follow-up sampling. (correct answer)
Explanation: Hazardous drug residue above threshold in the ante-area indicates a containment failure requiring comprehensive response: investigate the contamination source, decontaminate the affected area, assess personnel exposure, improve containment measures, and confirm remediation. D correctly identifies this comprehensive response. A is incorrect because ante-area contamination above threshold is a significant finding requiring action. B is incorrect because warning signs without remediation do not address the contamination. C is incorrect because increasing sampling frequency alone without addressing the contamination source is insufficient.

Question 6

A pharmacy conducts monthly environmental monitoring in its sterile compounding cleanroom. Results for the past three months show progressively increasing CFU counts that remain below action levels. Which of the following best describes the appropriate response?

  1. No response is required because action levels have not been exceeded.
  2. Conduct an investigation and review processes due to the increasing CFU trend. (correct answer)
  3. Increase the cleaning frequency only if action levels are exceeded next month.
  4. File a report with the state board of pharmacy describing the increasing trend.
Explanation: USP 797 incorporates alert levels -- thresholds below action levels that serve as early warning indicators. A trend of increasing CFU counts, even below action levels, warrants investigation and process review to prevent reaching action levels. B correctly identifies this proactive approach. A is incorrect because trending data below action levels should not be ignored. C is incorrect because waiting for action level exceedance before investigating a clear upward trend is reactive rather than proactive. D is incorrect because state board reporting is not triggered by below-action-level trending data.

Question 7

A sterile compounding pharmacy has not performed environmental monitoring for four months due to staff turnover and workload. The pharmacy has continued compounding throughout this period. Which of the following best analyzes the compliance concern?

  1. There is no compliance concern because the pharmacy would have noticed visible contamination if it had occurred.
  2. The pharmacy's failure to monitor for four months violates USP 797, risking undetected microbial contamination in compounded preparations. (correct answer)
  3. There is no compliance concern because staff turnover is a valid force majeure event that excuses monitoring failures.
  4. The compliance concern is minimal because the pharmacy can catch up by performing four months of monitoring simultaneously.
Explanation: A four-month monitoring gap is a serious USP 797 compliance failure. Sterile compounding during an unmonitored period means the environment's microbial status was unknown, which represents a patient safety risk. The pharmacy must resume monitoring, investigate the gap, and assess the potential impact. B correctly identifies the gravity of the situation. A is incorrect because microbial contamination is not visible to the naked eye and cannot be detected by observation. C is incorrect because staff turnover does not excuse compliance failures. D is incorrect because retrospective catch-up monitoring is not meaningful; the gap represents real time when contamination could have occurred undetected.

Question 8

A sterile compounding pharmacy's environmental monitoring identifies Staphylococcus aureus on the work surface of the ISO 5 laminar airflow workbench at levels exceeding the action level. Which of the following is the most appropriate immediate response?

  1. Continue compounding while filing an incident report to be reviewed at the monthly quality meeting.
  2. Increase the cleaning frequency by one additional cycle per day and continue compounding.
  3. Cease compounding, investigate contamination source, re-clean area, and perform follow-up environmental monitoring before resuming. (correct answer)
  4. Recall all preparations compounded since the last successful monitoring result, without conducting any further investigation.
Explanation: An action level exceedance requires ceasing compounding, investigating the root cause, implementing corrective measures, decontaminating the area, and confirming remediation through follow-up monitoring before resuming. C correctly identifies this comprehensive response. A is incorrect because continuing compounding with a deferred response ignores an immediate patient safety risk. B is incorrect because increasing cleaning frequency alone without investigation and confirmed remediation does not address the action level exceedance adequately. D is incorrect because immediate recall without investigation may be premature; the scope of impact must be assessed through investigation.

Question 9

Under USP Chapter 797, what is the primary purpose of environmental monitoring in a sterile compounding facility?

  1. To verify that compounding equipment meets DEA security specifications.
  2. To detect microbial contamination in the cleanroom environment. (correct answer)
  3. To satisfy state board of pharmacy audit requirements for facility licensure.
  4. To measure the temperature and humidity in the cleanroom for staff comfort.
Explanation: Environmental monitoring under USP 797 is designed to detect microbial contamination in the cleanroom environment, allowing the pharmacy to identify problems and take corrective action before sterility is compromised and patient harm occurs. B correctly identifies this protective purpose. A is incorrect because environmental monitoring addresses microbial contamination, not DEA security specifications. C is incorrect because while environmental monitoring records may be reviewed in inspections, the primary purpose is patient safety. D is incorrect because temperature and humidity monitoring serves formulation stability purposes, not staff comfort.

Question 10

Under USP Chapter 797, personnel must demonstrate competency in garbing through which of the following assessments?

  1. A written examination on garbing procedures and cleanroom policies.
  2. Observation by the pharmacist-in-charge with no documented testing required.
  3. A verbal quiz on garbing order and cleanroom SOPs.
  4. Gloved fingertip sampling to confirm no contamination during garbing. (correct answer)
Explanation: USP 797 requires gloved fingertip sampling as the primary competency assessment for garbing: after the individual has completed donning PPE, samples are taken from the fingertips of both gloved hands to demonstrate that the garbing process does not introduce microbial contamination. D correctly identifies this required assessment. A is incorrect because written examinations alone do not assess the hands-on competency that garbing requires. B is incorrect because documented testing is explicitly required, not just observed by the PIC. C is incorrect because verbal quizzes assess knowledge but not the procedural competency that fingertip sampling evaluates.

Question 11

Under USP Chapter 800, where must wipe sampling be performed to assess hazardous drug surface contamination?

  1. Only inside the biological safety cabinet or other containment primary engineering control.
  2. Only on the surfaces that personnel touch most frequently during hazardous drug compounding.
  3. In the compounding area and any location where hazardous drugs are stored or transported. (correct answer)
  4. Only on pharmacy countertops in the general dispensing area.
Explanation: USP 800 requires wipe sampling both within the compounding area and at locations outside where hazardous drugs may spread -- including transport corridors, ante-areas, and pass-throughs -- to detect migration of contamination. C correctly identifies this comprehensive sampling scope. A is incorrect because sampling only inside the PEC is insufficient to detect contamination spread. B is incorrect because sampling is location-based under USP 800, not limited to frequently touched surfaces. D is incorrect because general dispensing countertops are not the primary location of concern.

Question 12

Under USP Chapter 797, what must be done with environmental monitoring results that exceed action levels before compounding may resume in the affected area?

  1. The PIC must sign a waiver acknowledging awareness of the exceedance.
  2. Re-clean, investigate, correct, and confirm acceptable environmental levels before resuming compounding. (correct answer)
  3. Compounding may resume after 24 hours regardless of follow-up testing results.
  4. Compounding may resume if the pharmacist visually confirms the area appears clean.
Explanation: Before resuming compounding after an action level exceedance, USP 797 requires that re-cleaning and decontamination occur, a root cause investigation be completed, corrective actions be implemented, and follow-up environmental monitoring confirm acceptable results. B correctly identifies these required steps. A is incorrect because a PIC waiver is not a recognized mechanism for resuming compounding after an exceedance. C is incorrect because the 24-hour rule is not an appropriate standard; confirmed monitoring results determine readiness. D is incorrect because visual assessment of cleanliness does not detect microbial contamination.

Question 13

Under USP Chapter 797, how must environmental monitoring records be maintained and for how long?

  1. Records may be discarded once the affected preparations have been dispensed.
  2. Records must be retained only for the duration of the preparation's BUD.
  3. Records must be kept for at least one year and be available for inspection. (correct answer)
  4. Records must be submitted to the FDA on a quarterly basis.
Explanation: USP 797 requires environmental monitoring records to be retained for at least one year and organized to support trend analysis, with accessibility for inspection. State law may require longer retention. C correctly identifies these requirements. A is incorrect because records cannot be discarded after preparations are dispensed; the minimum retention period is one year. B is incorrect because retention is based on a calendar period, not the BUD of individual preparations. D is incorrect because FDA submission is not required for routine environmental monitoring records at 503A pharmacies.

Question 14

Under USP Chapter 797, which of the following must occur before a new cleanroom facility may begin compounding Category 2 CSPs?

  1. The facility must obtain a DEA registration before any environmental monitoring is performed.
  2. The facility must notify the state board of pharmacy of its intent to begin compounding.
  3. The facility must obtain state pharmacy licensure only; environmental testing may follow during the first month of operations.
  4. Initial environmental monitoring must be completed with acceptable results before starting Category 2 compounding in the cleanroom. (correct answer)
Explanation: Before a new facility begins Category 2 sterile compounding, USP 797 requires initial environmental qualification including surface sampling, air sampling, and non-viable particle counting to confirm that the cleanroom meets required ISO classifications and is suitable for sterile compounding. D correctly identifies this prerequisite. A is incorrect because DEA registration is unrelated to environmental monitoring prerequisites for sterile compounding. B is incorrect because state board notification, while potentially required, is not the operative USP 797 prerequisite. C is incorrect because environmental testing must be completed and show acceptable results before operations begin, not after.

Question 15

Under USP Chapter 797, what is the significance of identifying specific microbial species in environmental monitoring results?

  1. Species identification has no significance; only the total CFU count matters.
  2. Species identification is used only to determine if the contamination poses any insurance liability.
  3. Species identification helps trace contamination sources for targeted corrective actions. (correct answer)
  4. Species identification is only required for compounding facilities that dispense to multiple states.
Explanation: Species identification is a valuable diagnostic tool. The type of organism detected helps identify the likely source of contamination: skin flora suggests personnel practice issues, environmental organisms suggest HVAC or cleaning issues, and water-associated organisms suggest moisture intrusion. C correctly identifies this diagnostic utility. A is incorrect because species identity provides valuable root cause information. B is incorrect because insurance liability is not the purpose of species identification. D is incorrect because species identification is required for all Category 2 sterile compounding facilities under USP 797 regardless of distribution scope.

Question 16

Under USP Chapter 800, what environmental monitoring is required for hazardous drug compounding areas?

  1. Wipe sampling for surface contamination is required at defined intervals to ensure effective hazardous drug containment and clean compounding surfaces. (correct answer)
  2. Environmental monitoring for hazardous drug compounding areas is not required because hazardous drugs are toxic rather than susceptible to microbial contamination.
  3. Only particle counting is required for hazardous drug areas because chemical contamination is the primary concern, not microbial.
  4. Environmental monitoring for hazardous drugs requires only annual air quality testing.
Explanation: USP Chapter 800 requires wipe sampling of surfaces in and around the hazardous drug compounding area at defined intervals to verify that containment engineering controls are functioning and that hazardous drug residue has not spread beyond the designated areas. A correctly identifies wipe sampling for HD surface contamination as the primary environmental monitoring requirement under USP 800. B is incorrect because HD contamination monitoring is explicitly required under USP 800; the fact that HDs are chemically rather than microbially hazardous makes the chemical surface monitoring more critical, not less. C is incorrect because particle counting measures particulate and microbial air quality, not chemical contamination; wipe sampling for HD residue is the required monitoring approach. D is incorrect because wipe sampling must be performed at defined intervals consistent with the facility's operations, not only annually.

Question 17

Under USP Chapter 797, who is responsible for ensuring that environmental monitoring is conducted according to the written program and that results are reviewed and acted upon?

  1. The environmental monitoring contractor who performs the testing.
  2. The designated person overseeing sterile compounding operations. (correct answer)
  3. Individual compounding technicians are each personally responsible for monitoring results.
  4. The state board of pharmacy inspector who visits annually.
Explanation: Under USP 797, the designated person (DP) responsible for the sterile compounding operation bears overall accountability for ensuring that environmental monitoring is conducted per the written program and that results are reviewed and acted upon. B correctly identifies this responsibility. A is incorrect because contractors perform the testing but the pharmacy's DP retains overall accountability. C is incorrect because environmental monitoring oversight is a management-level responsibility, not an individual technician responsibility. D is incorrect because the state board inspector evaluates compliance but does not have operational responsibility for routine monitoring.

Question 18

Under USP Chapter 797, what ISO classification is required for the primary engineering control (PEC) used for sterile compounding?

  1. ISO 6, which permits up to 35,200 particles >= 0.5 micron per cubic meter.
  2. ISO 9, which is ambient room air quality.
  3. ISO 5, which allows up to 3,520 particles >= 0.5 micron per cubic meter. (correct answer)
  4. ISO 4, which is reserved for semiconductor manufacturing and is more stringent than required.
Explanation: USP 797 requires the primary engineering control -- where sterile preparations are directly exposed to the environment -- to meet ISO 5 classification, which permits no more than 3,520 particles >= 0.5 micron per cubic meter. C correctly identifies ISO 5 as the required PEC classification. A is incorrect because ISO 6 is less stringent than the required ISO 5. B is incorrect because ISO 9 is ambient room air and is far too permissive for a sterile compounding PEC. D is incorrect because ISO 4 exceeds requirements and is typically applied to semiconductor manufacturing, not pharmacy compounding.

Question 19

Under USP Chapter 797, which of the following is a required component of a written environmental monitoring program?

  1. Sampling locations, frequency, methods, growth media, action levels, and investigation procedures. (correct answer)
  2. Only the names of the vendors from whom growth media are purchased.
  3. Only the ISO classification of the cleanroom as certified by an external party.
  4. Only the schedule of when monitoring will occur each month.
Explanation: A comprehensive written environmental monitoring program must include: sampling locations, frequency, methods, growth media used, action and alert levels for each location, investigation and corrective action procedures, and responsible personnel. A correctly identifies these required components. B is incorrect because vendor information alone is far too narrow. C is incorrect because the ISO certification is one element but the written program must be far more comprehensive. D is incorrect because scheduling alone omits methods, action levels, and corrective action procedures.

Question 20

Under USP Chapter 797, what are action levels in environmental monitoring, and what must occur when they are exceeded?

  1. Action levels are target concentrations for cleaning agents; exceeding them requires purchasing new cleaning supplies.
  2. Action levels are staff performance benchmarks; exceeding them requires additional training hours.
  3. Action levels are staffing thresholds that determine when additional compounding personnel must be scheduled.
  4. Action levels are microbial limits; exceeding them requires investigation, corrective actions, and re-testing. (correct answer)
Explanation: Action levels are defined contamination thresholds under USP 797. When results exceed action levels, the facility must investigate the source of contamination, identify the root cause, implement corrective actions, and confirm through re-testing that the environment has returned to acceptable limits before resuming compounding. D correctly describes this framework. A is incorrect because action levels relate to microbial counts, not cleaning agent concentrations. B is incorrect because action levels are environmental, not personnel performance metrics. C is incorrect because action levels are microbial contamination thresholds, not staffing thresholds.